Format

Send to

Choose Destination
Int J Biochem Cell Biol. 2013 Aug;45(8):1927-38. doi: 10.1016/j.biocel.2013.06.007. Epub 2013 Jun 19.

Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.

Author information

1
Servei de Neurologia, Laboratori de Neurologia Experimental, Hospital de la Santa Creu i Sant Pau i Institut de Recerca de HSCSP, Barcelona, Spain.

Abstract

Dysferlinopathies are a group of progressive muscular dystrophies characterized by mutations in the gene DYSF. These mutations cause scarcity or complete absence of dysferlin, a protein that is expressed in skeletal muscle and plays a role in membrane repair. Our objective was to unravel the proteins that constitute the dysferlin complex and their interaction within the complex using immunoprecipitation assays (IP), blue native gel electrophoresis (BN) in healthy adult skeletal muscle and healthy cultured myotubes, and fluorescence lifetime imaging-fluorescence resonance energy transfer (FLIM-FRET) analysis in healthy myotubes. The combination of immunoprecipitations and blue native electrophoresis allowed us to identify previously reported partners of dysferlin - such as caveolin-3, AHNAK, annexins, or Trim72/MG53 - and new interacting partners. Fluorescence lifetime imaging showed a direct interaction of dysferlin with Trim72/MG53, AHNAK, cytoplasmic dynein, myomesin-2 and calsequestrin-1, but not with caveolin-3 or dystrophin. In conclusion, although IP and BN are useful tools to identify the proteins in a complex, techniques such as fluorescence lifetime imaging analysis are needed to determine the direct and indirect interactions of these proteins within the complex. This knowledge may help us to better understand the roles of dysferlin in muscle tissue and identify new genes involved in muscular dystrophies in which the responsible gene is unknown.

KEYWORDS:

Blue native; CALQ1; Cav-3; Cytoplasmic dynein; DHPR; DMD; DYNC1LI2; Duchenne muscular dystrophy; Dysferlin; FLIM–FRET; FLIM–FRET analysis; FSHD; HAC6; LGMD1C; LGMD2B; MM; MYOM2; Miyoshi myopathy; PTRF; RRC; SERCA; SR; Trim72/MG53; calsequestrin-1; caveolin-3; cytoplasmic dynein 1 light intermediate chain 2; dihydropyridine receptor; fascio-scapulo-humeral dystrophy; fluorescence lifetime imaging–fluorescence resonance energy transfer; histone deacetylase 6; limb girdle muscular dystrophy 1C; limb girdle muscular dystrophy 2B; myomesin-2; polymerase I and transcript release factor; receptor recycling compartment; sarcoplasmic reticulum; sarcoplasmic/endoplasmic reticulum calcium ATPase; trim72/MG53; tripartite containing motif 72/mitsugumin 53

PMID:
23792176
DOI:
10.1016/j.biocel.2013.06.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center